| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
6,158 |
5,574 |
$201K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
7,965 |
7,380 |
$154K |
| 52000 |
|
1,944 |
1,766 |
$144K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
1,592 |
987 |
$118K |
| 99244 |
Office or other outpatient consultation, moderate to high complexity |
734 |
637 |
$108K |
| 51798 |
|
10,819 |
10,079 |
$90K |
| 88121 |
|
639 |
609 |
$73K |
| G2023 |
Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
2,099 |
1,322 |
$49K |
| 82570 |
|
9,605 |
7,737 |
$41K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
774 |
734 |
$32K |
| 88112 |
|
999 |
965 |
$31K |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
1,116 |
688 |
$27K |
| 81003 |
|
9,539 |
7,719 |
$19K |
| 88313 |
|
1,010 |
976 |
$18K |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
404 |
221 |
$17K |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
423 |
413 |
$14K |
| 76872 |
|
116 |
103 |
$8K |
| 99215 |
Prolong outpt/office vis |
91 |
81 |
$5K |
| 51741 |
|
232 |
212 |
$4K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
102 |
89 |
$4K |
| 99243 |
|
33 |
26 |
$3K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
157 |
119 |
$2K |
| 55700 |
|
19 |
12 |
$2K |
| 51784 |
|
45 |
35 |
$1K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
35 |
30 |
$796.71 |
| 84153 |
|
45 |
44 |
$534.60 |
| 36415 |
Collection of venous blood by venipuncture |
653 |
580 |
$188.43 |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
16 |
12 |
$169.37 |
| 99222 |
Initial hospital care, per day, moderate complexity |
41 |
40 |
$168.56 |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
21 |
15 |
$137.34 |
| 99442 |
|
74 |
62 |
$80.55 |
| 99072 |
|
174 |
151 |
$64.65 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
20 |
13 |
$27.47 |
| G8427 |
Eligible clinician attests to documenting in the medical record they obtained, updated, or reviewed the patient's current medications |
2,693 |
2,041 |
$5.72 |
| 1111F |
|
2,091 |
1,609 |
$3.14 |
| G8420 |
Bmi is documented within normal parameters and no follow-up plan is required |
2,269 |
1,785 |
$0.08 |
| G8417 |
Bmi is documented above normal parameters and a follow-up plan is documented |
344 |
295 |
$0.00 |